reviewNature Reviews Drug DiscoveryMar 6, 2024Closed access

The present and future of bispecific antibodies for cancer therapy

CKChristian KleinUBUlrich BrinkmannJMJanice M. ReichertRERoland E. Kontermann

Roche (Switzerland) · Roche Pharma AG (Germany) · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

402
total citations
FWCI
151.79
Percentile
100%
References
309
Citations per year

Authors

4

Topics & keywords

Topics
Keywords
  • Bispecific antibody
  • Cancer therapy
  • Cancer immunotherapy
  • Cancer
  • Immunotherapy
  • Medicine
  • Cancer research
  • Antibody
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.